Muscle-relaxant Orfenace 100 Mg Tablets Recalled Because Of Nitrosamine Impurity
Recall Summary OrfenAce 100 mg tablets are being recalled across Canada because they contain higher-than-acceptable levels of nitrosamine, a chemical impurity that poses a potential health risk. This recall affects all batches of this muscle-relaxant medication. The impurity was discovered during quality testing.
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2021-04-16
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/d49982a0-09f6-4341-8d79-bf7f4ee3c641